Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2003
High-dose therapy for follicular lymphoma revisited: not if, but when?
T Andrew Lister
The New England Journal of Medicine
|
March 27, 2004
Who should receive myeloablative therapy for lymphoma?
T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2005
Improved survival for patients with follicular lymphoma
T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective
T Andrew Lister
Hematology/Oncology Clinics of North America
|
August 9, 2005
Secondary central nervous system lymphoma: risk factors and prophylaxis
Silvia Montoto, T Andrew Lister
Best Practice & Research. Clinical Haematology
|
February 8, 2005
The clinical course of follicular lymphoma
Ama Z S Rohatiner, T Andrew Lister
Methods in Molecular Medicine
|
July 7, 2005
Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma
Kim Last, Silvana Debarnardi, T Andrew Lister
Hematology. American Society of Hematology. Education Program
|
November 26, 2002
Central nervous system lymphoma
Andrew Lister, Lauren E Abrey, John T Sandlund
British Journal of Haematology
|
April 3, 2014
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma - response to Meissner et al
Paul Greaves, T Andrew Lister, John G Gribben
The Veterinary Record
|
June 8, 2021
Impact assessment of the reduction or removal of ionophores used for controlling coccidiosis in the UK broiler industry
Charles Daniel Parker, Stephen Andrew Lister, Jason Gittins
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2003
High-dose therapy for follicular lymphoma revisited: not if, but when?
T Andrew Lister
The New England Journal of Medicine
|
March 27, 2004
Who should receive myeloablative therapy for lymphoma?
T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2005
Improved survival for patients with follicular lymphoma
T Andrew Lister
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective
T Andrew Lister
Hematology/Oncology Clinics of North America
|
August 9, 2005
Secondary central nervous system lymphoma: risk factors and prophylaxis
Silvia Montoto, T Andrew Lister
Best Practice & Research. Clinical Haematology
|
February 8, 2005
The clinical course of follicular lymphoma
Ama Z S Rohatiner, T Andrew Lister
Methods in Molecular Medicine
|
July 7, 2005
Molecular diagnosis of lymphoma: outcome prediction by gene expression profiling in diffuse large B-cell lymphoma
Kim Last, Silvana Debarnardi, T Andrew Lister
Hematology. American Society of Hematology. Education Program
|
November 26, 2002
Central nervous system lymphoma
Andrew Lister, Lauren E Abrey, John T Sandlund
British Journal of Haematology
|
April 3, 2014
Parenthood in long-term survivors after CHOP with or without etoposide treatment for aggressive lymphoma - response to Meissner et al
Paul Greaves, T Andrew Lister, John G Gribben
The Veterinary Record
|
June 8, 2021
Impact assessment of the reduction or removal of ionophores used for controlling coccidiosis in the UK broiler industry
Charles Daniel Parker, Stephen Andrew Lister, Jason Gittins
Page
of 12